[1]李 莉,吴 健,窦一田.益气养阴固脱法防治透析相关性低血压疗效的Meta分析[J].医学信息,2021,34(18):90-93,98.[doi:10.3969/j.issn.1006-1959.2021.18.023]
 LI Li,WU Jian,DOU Yi-tian.Meta-analysis of the Curative Effect of Yiqi Yangyin Gutuo Method in Preventingand Treating Dialysis-related Hypotension[J].Medical Information,2021,34(18):90-93,98.[doi:10.3969/j.issn.1006-1959.2021.18.023]
点击复制

益气养阴固脱法防治透析相关性低血压疗效的Meta分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年18期
页码:
90-93,98
栏目:
论著
出版日期:
2021-09-18

文章信息/Info

Title:
Meta-analysis of the Curative Effect of Yiqi Yangyin Gutuo Method in Preventingand Treating Dialysis-related Hypotension
文章编号:
1006-1959(2021)18-0090-05
作者:
李 莉1吴 健1窦一田2
1.天津市和平区中医医院血透中心,天津 300050;2.天津中医药大学第一附属医院肾病科,天津 300193
Author(s):
LI Li1WU Jian1DOU Yi-tian2
1.Hemodialysis Center,Heping District Traditional Chinese Medicine Hospital,Tianjin 300050,China;2.Department of Nephrology,the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300193,China
关键词:
血液透析低血压益气养阴固脱法平均动脉压
Keywords:
HemodialysisHypotensionYiqi Yangyin Gutuo methodMean arterial pressure
分类号:
R277.5
DOI:
10.3969/j.issn.1006-1959.2021.18.023
文献标志码:
A
摘要:
目的 系统评价益气滋阴固脱法防治透析相关性低血压的效果。方法 计算机检索中国知网数据库(CNKI)、万方数据库(WanFang)、维普数据库(VIP)、PubMed、The Cochrane Library及Web of Science中有关益气养阴固脱法防治透析相关性低血压的随机对照实验,检索时间限定为2000年1月1日-2020年12月30日,根据Cochrane偏倚风险评估工具对纳入文献进行质量评价,采用RevMan5.3软件进行Meta分析。结果 共纳入11项随机对照试验,共1091例患者,其中试验组588例,对照组503例。Meta分析结果显示,试验组总有效率高于对照组(RR=1.28,95%CI:1.19~1.37,P<0.00001);试验组平均动脉压在透析中(MD=11.11,95%CI:7.61~14.62,P<0.00001)及透析后(MD=8.7,95%CI:6.02~11.38,P<0.00001)均高于对照组。结论 基于目前证据,益气养阴固脱法防治透析相关性低血压疗效确切,但尚需高质量研究进一步验证。
Abstract:
Objective To systematically evaluate the effect of Yiqi Ziyin Gutuo method in preventing and treating dialysis-related hypotension.Methods A computer search of China National Knowledge Base (CNKI), WanFang database (WanFang), VIP database (VIP), PubMed, The Cochrane Library, and Web of Science for the prevention and treatment of dialysis-related hypotension with Yiqi Yangyin Gutuo method experiment, the search time was limited to January 1, 2000-December 30, 2020.According to the Cochrane bias risk assessment tool, the quality of the included literature was evaluated, and the RevMan5.3 software was used for meta-analysis.Results A total of 11 randomized controlled trials were included, with a total of 1091 patients, including 588 in the experimental group and 503 in the control group.Meta analysis results showed that the total effective rate of the experimental group was higher than that of the control group (RR=1.28, 95CI: 1.19-1.37, P<0.00001);The mean arterial pressure in the experimentalgroup during dialysis (MD=11.11, 95%CI: 7.61-14.62, P<0.00001) and after dialysis (MD=8.7, 95%CI: 6.02-11.38, P<0.00001) were higher than those in the control group.Conclusion Based on current evidence,Yiqi Yangyin Gutuo method is effective in preventing and treating dialysis-related hypotension, but it needs further verification by high-quality research.

参考文献/References:

[1]谢超,马济佩,朱敏.透析中低血压的中医药治疗文献回顾[J].内蒙古中医药,2016,35(14):150-151.[2]池向耿,李香茶,蔡琪,等.维持性血液透析患者体液分布与透析相关低血压的关系[J].中国血液净化,2014,13(11):767-771.[3]危志强,章旭,蔡小琴,等.不同组合透析方案对维持性血液透析患者相关并发症的影响[J].临床肾脏病杂志,2019,19(7):516-519.[4]刘文虎,孙雪峰,林洪丽,等.中国血液透析充分性临床实践指南[J].中华医学杂志,2015,95(34):2748-2753. [5]Cumpston M,Li T,Page MJ,et al.Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions[J].Cochrane Database Syst Rev,2019(10):ED000142.[6]刘绛,苏勇.生脉注射液对血透相关性低血压患者的疗效观察[J].中国临床实用医学,2010(12):62-63.[7]王巧玲.生脉注射液治疗血液透析相关性低血压临床观察[J].中国现代药物应用,2013,7(11):19-20.[8]史玉生,钱隽.管通、参麦注射液治疗透析性低血压疗效观察[J].现代医药卫生,2005(24):30-31.[9]林玲,彭梅,罗凯,等.参麦注射液对血液透析相关性低血压患者血压、血清白蛋白及透析充分性的影响[J].河北中医,2019,41(5):706-709.[10]范立明,黄远航,钟先阳.参麦注射液防治血液透析相关性低血压的临床疗效及对透析充分性的影响[J].河北中医,2018,40(4):531-534.[11]蔡红.参麦注射液防治血液透析患者低血压的临床观察[D].武汉:湖北中医药大学,2014.[12]赵先锋.参附注射液防治老年血透相关性低血压临床观察[J].中国中医药信息杂志,2012,19(12):65-67.[13]赵虎康.生脉注射液防治血液透析相关性低血压的疗效观察[D].北京:北京中医药大学,2007.[14]郑淑婷,李娜,侯波.生脉注射液联合50%葡萄糖治疗老年透析相关性低血压[J].临床误诊误治,2009,22(2):34-36.[15]蒋宇峰,何立群,沈沛成.生脉注射液联合管通治疗血透相关性低血压的疗效观察[J].新中医,2006(10):61-62.[16]陈云庆.参附注射液预冲管路在血液透析相关低血压中的应用[J].中医临床研究,2011,3(19):104-105.[17]林辉遂,朱林勋,黄菊,等.参附注射液联合可调钠对透析相关性低血压的疗效观察[J].云南中医中药杂志,2021,42(1):41-42.[18]濮红梅,冯锦红,刘秉成,等.环磷腺苷葡胺联合低温可调钠透析治疗透析中低血压的临床疗效研究[J].中国全科医学,2018,21(15):4-51.[19]江巧梨,许帅,邹洪斌.生脉饮联合参类治疗中老年血液透析相关性低血压[J].长春中医药大学学报,2018,34(1):114-115.[20]范立明,黄远航,钟先阳.麦注射液防治血液透析相关性低血压的临床疗效及对透析充分性的影响[J].河北中医,2018,40(4):531-534.

相似文献/References:

[1]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
 ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Medical Information,2018,31(18):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[2]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
 WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Medical Information,2018,31(18):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[3]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
 FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Medical Information,2019,32(18):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[4]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
 JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Medical Information,2018,31(18):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[5]赵 立,褚海辰,梁永新.苯肾上腺素预输注防治老年人脊麻后低血压的临床研究[J].医学信息,2018,31(20):81.[doi:10.3969/j.issn.1006-1959.2018.20.023]
 ZHAO Li,CHU Hai-chen,LIANG Yong-xin.Clinical Study of Phenylephrine Pre-infusion for Prevention and Treatment of Hypotension after Spinal Anesthesia in the Elderly[J].Medical Information,2018,31(18):81.[doi:10.3969/j.issn.1006-1959.2018.20.023]
[6]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
 ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Medical Information,2019,32(18):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[7]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
 XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Medical Information,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[8]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
 YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Medical Information,2019,32(18):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[9]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
 WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Medical Information,2019,32(18):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
[10]王艳霞.中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响[J].医学信息,2022,35(17):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
 WANG Yan-xia.Effect of Traditional Chinese Herb Enema on Adverse Reactions of Constipation,Loss of Appetite and Vomiting in Uremic Hemodialysis Patients[J].Medical Information,2022,35(18):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
[11]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
 XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Medical Information,2018,31(18):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]

更新日期/Last Update: 1900-01-01